{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:31:52Z","timestamp":1793640712886,"version":"4.5.1"},"reference-count":67,"publisher":null,"issue":"4","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/lib.ossn.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kardiologiia"],"abstract":"<jats:p>The novel coronavirus infection, COVID-19, is a highly contagious viral disease associated with acute, severe respiratory syndrome, which is based on the development of pronounced thrombo-inflammatory syndrome. As the number of patients with COVID-19 increased, heart damage has been reported, especially in patients with severe and critical COVID-19. This review describes the role of angiotensin-converting enzyme 2 receptor in the regulation of viral entry, the variety of damages to the heart and coronary arteries, and the importance of arterial hypertension and of the use of renin-angiotensin-aldosterone system inhibitors in the prognosis of patients with COVID-19.<\/jats:p>","DOI":"10.18087\/cardio.2021.4.n1408","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T07:35:40Z","timestamp":1621236940000},"page":"15-23","source":"Crossref","is-referenced-by-count":7,"title":["Cardiac Involvement in COVID-19"],"prefix":"10.68900","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8255-4159","authenticated-orcid":true,"given":"A. B.","family":"Sugraliyev","sequence":"first","affiliation":[{"name":"Kazakh National Medical University, Almaty, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":null,"published-online":{"date-parts":[[2021,5,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiology. 2020;5(7):802\u201310. DOI: 10.1001\/jamacardio.2020.0950","DOI":"10.1001\/jamacardio.2020.0950"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology. 2019;17(3):181\u201392. DOI: 10.1038\/s41579-018-0118-9","DOI":"10.1038\/s41579-018-0118-9"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u20133. DOI: 10.1038\/s41586-020-2012-7","DOI":"10.1038\/s41586-020-2012-7"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN et al. Aerosol and Surface Stability of SARSCoV-2 as Compared with SARS-CoV-1. New England Journal of Medicine. 2020;382(16):1564\u20137. DOI: 10.1056\/NEJMc2004973","DOI":"10.1056\/NEJMc2004973"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. International Journal of Infectious Diseases. 2020;92:214\u20137. DOI: 10.1016\/j.ijid.2020.01.050","DOI":"10.1016\/j.ijid.2020.01.050"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak \u2013 an update on the status. Military Medical Research. 2020;7(1):11. DOI: 10.1186\/s40779-020-00240-0","DOI":"10.1186\/s40779-020-00240-0"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Science China Life Sciences. 2020;63(3):364\u201374. DOI: 10.1007\/s11427-020-1643-8","DOI":"10.1007\/s11427-020-1643-8"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054\u201362. DOI: 10.1016\/S0140-6736(20)30566-3","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181(2):281-292.e6. DOI: 10.1016\/j.cell.2020.02.058","DOI":"10.1016\/j.cell.2020.02.058"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444\u20138. DOI: 10.1126\/science.abb2762","DOI":"10.1126\/science.abb2762"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Santos RAS, Sampaio WO, Alzamora AC, Motta-Santos D, Alenina N, Bader M et al. The ACE2\/Angiotensin-(1\u20137)\/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1\u20137). Physiological Reviews. 2018;98(1):505\u201353. DOI: 10.1152\/physrev.00023.2016","DOI":"10.1152\/physrev.00023.2016"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450\u20134. DOI: 10.1038\/nature02145","DOI":"10.1038\/nature02145"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-280.e8. DOI: 10.1016\/j.cell.2020.02.052","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Wu Y. Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury. Virologica Sinica. 2020;35(3):256\u20138. DOI: 10.1007\/s12250-020-00205-6","DOI":"10.1007\/s12250-020-00205-6"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. The Journal of Pathology. 2004;203(2):631\u20137. DOI: 10.1002\/path.1570","DOI":"10.1002\/path.1570"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious Diseases. 2020;20(5):533\u20134. DOI: 10.1016\/S1473-3099(20)30120-1","DOI":"10.1016\/S1473-3099(20)30120-1"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A et al. COVID-19 and Cardiovascular Disease. Circulation. 2020;141(20):1648\u201355. DOI: 10.1161\/CIRCULATIONAHA.120.046941","DOI":"10.1161\/CIRCULATIONAHA.120.046941"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Shi Y, Yu X, Zhao H, Wang H, Zhao R, Sheng J. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan. Critical Care. 2020;24(1):108. DOI: 10.1186\/s13054-020-2833-7","DOI":"10.1186\/s13054-020-2833-7"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus\u20102 (SARS\u2010CoV\u20102) Requiring Invasive Mechanical Ventilation. Obesity. 2020;28(7):1195\u20139. DOI: 10.1002\/oby.22831","DOI":"10.1002\/oby.22831"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology. 2020;146(1):110\u20138. DOI: 10.1016\/j.jaci.2020.04.006","DOI":"10.1016\/j.jaci.2020.04.006"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care. 2020;43(7):1392\u20138. DOI: 10.2337\/dc20-0576","DOI":"10.2337\/dc20-0576"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Internal Medicine. 2020;180(7):934\u201343. DOI: 10.1001\/jamainternmed.2020.0994","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Shibata S, Arima H, Asayama K, Hoshide S, Ichihara A, Ishimitsu T et al. Hypertension and related diseases in the era of COVID-19: areport from the Japanese Society of Hypertension Task Force on COVID-19. Hypertension Research. 2020;43(10):1028\u201346. DOI: 10.1038\/s41440-020-0515-0","DOI":"10.1038\/s41440-020-0515-0"},{"key":"ref24","unstructured":"Centers for Disease Control and Prevention. People at Increased Risk for Severe Illness. 2020. [Internet] Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/index.html"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Williams B, Zhang Y. Hypertension, renin\u2013angiotensin\u2013aldosterone system inhibition, and COVID-19. The Lancet. 2020;395(10238):1671\u20133. DOI: 10.1016\/S0140-6736(20)31131-4","DOI":"10.1016\/S0140-6736(20)31131-4"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P et al. SARS-CoV2: should inhibitors of the renin\u2013angiotensin system be withdrawn in patients with COVID-19? European Heart Journal. 2020;41(19):1801\u20133. DOI: 10.1093\/eurheartj\/ehaa235","DOI":"10.1093\/eurheartj\/ehaa235"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA et al. Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac AngiotensinConverting Enzyme 2. Circulation. 2005;111(20):2605\u201310. DOI: 10.1161\/CIRCULATIONAHA.104.510461","DOI":"10.1161\/CIRCULATIONAHA.104.510461"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Deshotels MR, Xia H, Sriramula S, Lazartigues E, Filipeanu CM. Angiotensin II Mediates Angiotensin Converting Enzyme Type 2 Internalization and Degradation Through an Angiotensin II Type I Receptor\u2013Dependent Mechanism. Hypertension. 2014;64(6):1368\u201375. DOI: 10.1161\/HYPERTENSIONAHA.114.03743","DOI":"10.1161\/HYPERTENSIONAHA.114.03743"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin\u2013Angiotensin\u2013Aldosterone System Inhibitors in Patients with Covid-19. New England Journal of Medicine. 2020;382(17):1653\u20139. DOI: 10.1056\/NEJMsr2005760","DOI":"10.1056\/NEJMsr2005760"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Danser AHJ, Epstein M, Batlle D. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers. Hypertension. 2020;75(6):1382\u20135. DOI: 10.1161\/HYPERTENSIONAHA.120.15082","DOI":"10.1161\/HYPERTENSIONAHA.120.15082"},{"key":"ref31","unstructured":"Sun ML, Yang JM, Sun YP, Su GH. Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia. Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases. 2020;43(3):219\u201322. DOI: 10.3760\/cma.j.issn.1001-0939.2020.03.016"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"de Abajo FJ, Rodr\u00edguez-Mart\u00edn S, Lerma V, Mej\u00eda-Abril G, Aguilar M, Garc\u00eda-Luque A et al. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a casepopulation study. The Lancet. 2020;395(10238):1705\u201314. DOI: 10.1016\/S0140-6736(20)31030-8","DOI":"10.1016\/S0140-6736(20)31030-8"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Li J, Wang X, Chen J, Zhang H, Deng A. Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China. JAMA Cardiology. 2020;5(7):825\u201330. DOI: 10.1001\/jamacardio.2020.1624","DOI":"10.1001\/jamacardio.2020.1624"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. New England Journal of Medicine. 2020;382(25):2431\u201340. DOI: 10.1056\/NEJMoa2006923","DOI":"10.1056\/NEJMoa2006923"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Bean DM, Kraljevic Z, Searle T, Bendayan R, Kevin O, Pickles A et al. Angiotensin\u2010converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID\u201019 infection in a multi\u2010site UK acute hospital trust. European Journal of Heart Failure. 2020;22(6):967\u201374. DOI: 10.1002\/ejhf.1924","DOI":"10.1002\/ejhf.1924"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Zhang P, Zhu L, Cai J, Lei F, Qin J-J, Xie J et al. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19. Circulation Research. 2020;126(12):1671\u201381. DOI: 10.1161\/CIRCRESAHA.120.317134","DOI":"10.1161\/CIRCRESAHA.120.317134"},{"key":"ref37","unstructured":"American College of Cardiology. HFSA\/ACC\/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. Av. at: https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2020\/03\/17\/08\/59\/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19. 2020."},{"key":"ref38","unstructured":"European Society of Cardiology. Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers. 2020. [Internet] Available at: https:\/\/www.escardio.org\/Councils\/Council-on-Hypertension-(CHT)\/News\/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Shlyakho E.V., Konradi A.O., Arutyunov G.P., Arutyunov A.G., Bautin A.E., Boytsov S.A. et al. Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemic. Russian Journal of Cardiology. 2020;25(3):129\u201348. DOI: 10.15829\/1560-4071-2020-3-3801","DOI":"10.15829\/1560-4071-2020-3-3801"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Lopes RD, Macedo AVS, de Barros e Silva PGM, Moll-Bernardes RJ, Feldman A, D\u2019Andr\u00e9a Saba Arruda G et al. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-The BRACE CORONA Trial. American Heart Journal. 2020;226:49\u201359. DOI: 10.1016\/j.ahj.2020.05.002","DOI":"10.1016\/j.ahj.2020.05.002"},{"key":"ref41","unstructured":"European Society of Cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. Last updated on 10 June 2020. Av. at: https:\/\/www.escardio.org\/Education\/COVID-19-and-Cardiology\/ESC-COVID-19-Guidance."},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. 2020;5(7):811\u20138. DOI: 10.1001\/jamacardio.2020.1017","DOI":"10.1001\/jamacardio.2020.1017"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nature Reviews Cardiology. 2020;17(5):259\u201360. DOI: 10.1038\/s41569-020-0360-5","DOI":"10.1038\/s41569-020-0360-5"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Cosyns B, Lochy S, Luchian ML, Gimelli A, Pontone G, Allard SD et al. The role of cardiovascular imaging for myocardial injury in hospitalized COVID-19 patients. European Heart Journal Cardiovascular Imaging. 2020;21(7):709\u201314. DOI: 10.1093\/ehjci\/jeaa136","DOI":"10.1093\/ehjci\/jeaa136"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. 2020;5(7):819\u201324. DOI: 10.1001\/jamacardio.2020.1096","DOI":"10.1001\/jamacardio.2020.1096"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Yancy CW, Fonarow GC. Coronavirus Disease 2019 (COVID-19) and the Heart\u2014Is Heart Failure the Next Chapter? JAMA Cardiology. 2020;5(11):1216\u20137. DOI: 10.1001\/jamacardio.2020.3575","DOI":"10.1001\/jamacardio.2020.3575"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Shi S, Qin M, Cai Y, Liu T, Shen B, Yang F et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. European Heart Journal. 2020;41(22):2070\u20139. DOI: 10.1093\/eurheartj\/ehaa408","DOI":"10.1093\/eurheartj\/ehaa408"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Toth E, Dancy L, Amin-Youssef G, Papachristidis A, Dworakowski R. Collateral implications of the COVID-19 pandemic: belated presentation of infective endocarditis in a young patient. European Heart Journal. 2020;41(45):4365. DOI: 10.1093\/eurheartj\/ehaa633","DOI":"10.1093\/eurheartj\/ehaa633"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Hua A, O\u2019Gallagher K, Sado D, Byrne J. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19. European Heart Journal. 2020;41(22):2130. DOI: 10.1093\/eurheartj\/ehaa253","DOI":"10.1093\/eurheartj\/ehaa253"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Kesici S, Aykan HH, Orhan D, Bayrakci B. Fulminant COVID-19-related myocarditis in an infant. European Heart Journal. 2020;41(31):3021. DOI: 10.1093\/eurheartj\/ehaa515","DOI":"10.1093\/eurheartj\/ehaa515"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Sala S, Peretto G, Gramegna M, Palmisano A, Villatore A, Vignale D et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. European Heart Journal. 2020;41(19):1861\u20132. DOI: 10.1093\/eurheartj\/ehaa286","DOI":"10.1093\/eurheartj\/ehaa286"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Solano-L\u00f3pez J, S\u00e1nchez-Recalde A, Zamorano JL. SARS-CoV-2, a novel virus with an unusual cardiac feature: inverted takotsubo syndrome. European Heart Journal. 2020;41(32):3106. DOI: 10.1093\/eurheartj\/ehaa390","DOI":"10.1093\/eurheartj\/ehaa390"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Meyer P, Degrauwe S, Van Delden C, Ghadri J-R, Templin C. Typical takotsubo syndrome triggered by SARS-CoV-2 infection. European Heart Journal. 2020;41(19):1860. DOI: 10.1093\/eurheartj\/ehaa306","DOI":"10.1093\/eurheartj\/ehaa306"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Bonnet M, Champagnac A, Lantelme P, Harbaoui B. Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2. European Heart Journal. 2020;41(39):3863\u20134. DOI: 10.1093\/eurheartj\/ehaa588","DOI":"10.1093\/eurheartj\/ehaa588"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Shergill S, Davies J, Bloomfield J. Florid aortitis following SARSCoV-2 infection. European Heart Journal. 2020;41(44):4286. DOI: 10.1093\/eurheartj\/ehaa635","DOI":"10.1093\/eurheartj\/ehaa635"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Wichmann D, Sperhake J-P, L\u00fctgehetmann M, Steurer S, Edler C, Heinemann A et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Annals of Internal Medicine. 2020;173(4):268\u201377. DOI: 10.7326\/M20-2003","DOI":"10.7326\/L20-1206"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Lax SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C et al. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series. Annals of Internal Medicine. 2020;173(5):350\u201361. DOI: 10.7326\/M20-2566","DOI":"10.7326\/M20-2566"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Ciceri F, Beretta L, Scandroglio AM, Colombo S, Landoni G, Ruggeri A et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Critical Care and Resuscitation. 2020;22(2):95\u20137. PMID: 32294809","DOI":"10.51893\/2020.2.pov2"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Sugraliyev A.B., Cirillo P. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome. Prevention of venous thromboembolism in patients with COVID-19. Medicine (Almaty). 2020;3\u20134:2\u20137.","DOI":"10.31082\/1728-452X-2020-213-214-3-4-2-7"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Hu D, Liu K, Li B, Hu Z. Large intracardiac thrombus in a COVID-19 patient treated with prolonged extracorporeal membrane oxygenation implantation. European Heart Journal. 2020;41(32):3104\u20135. DOI: 10.1093\/eurheartj\/ehaa524","DOI":"10.1093\/eurheartj\/ehaa524"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Ueki Y, Otsuka T, Windecker S, R\u00e4ber L. ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrome. European Heart Journal. 2020;41(22):2134. DOI: 10.1093\/eurheartj\/ehaa399","DOI":"10.1093\/eurheartj\/ehaa399"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Dominguez-Erquicia P, Dobarro D, Raposeiras-Roub\u00edn S, BastosFernandez G, I\u00f1iguez-Romo A. Multivessel coronary thrombosis in a patient with COVID-19 pneumonia. European Heart Journal. 2020;41(22):2132. DOI: 10.1093\/eurheartj\/ehaa393","DOI":"10.1093\/eurheartj\/ehaa393"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Fernandez Gasso L, Maneiro Melon NM, Sarnago Cebada F, Solis J, Garcia Tejada J. Multivessel spontaneous coronary artery dissection presenting in a patient with severe acute SARS-CoV-2 respiratory infection. European Heart Journal. 2020;41(32):3100\u20131. DOI: 10.1093\/eurheartj\/ehaa400","DOI":"10.1093\/eurheartj\/ehaa400"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Dweck MR, Bularga A, Hahn RT, Bing R, Lee KK, Chapman AR et al. Global evaluation of echocardiography in patients with COVID-19. European Heart Journal Cardiovascular Imaging. 2020;21(9):949\u201358. DOI: 10.1093\/ehjci\/jeaa178","DOI":"10.1093\/ehjci\/jeaa178"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Skulstad H, Cosyns B, Popescu BA, Galderisi M, Salvo GD, Donal E et al. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. European Heart Journal \u2013 Cardiovascular Imaging. 2020;21(6):592\u20138. DOI: 10.1093\/ehjci\/jeaa072","DOI":"10.1093\/ehjci\/jeaa072"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Linschoten M, Asselbergs FW. CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic. European Heart Journal. 2020;41(19):1795\u20136. DOI: 10.1093\/eurheartj\/ehaa280","DOI":"10.1093\/eurheartj\/ehaa280"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. 2020;5(11):1265\u201373. DOI: 10.1001\/jamacardio.2020.3557","DOI":"10.1001\/jamacardio.2020.3557"}],"container-title":["Kardiologiia"],"original-title":[],"link":[{"URL":"https:\/\/lib.ossn.ru\/jour\/article\/viewFile\/1408\/971","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:17:53Z","timestamp":1793639873000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.elpub.ru\/jour\/article\/view\/1408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":67,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,5,6]]}},"URL":"https:\/\/doi.org\/10.18087\/cardio.2021.4.n1408","relation":{},"ISSN":["2412-5660","0022-9040"],"issn-type":[{"value":"2412-5660","type":"electronic"},{"value":"0022-9040","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,6]]}}}